Incyte
Howard Kallender is an experienced clinical research scientist who has held various leadership positions in companies such as GlaxoSmithKline, Novartis Oncology, and currently at Incyte. With a background in Molecular Virology and Biochemistry, Howard has been involved in a wide range of clinical programs in areas such as immuno-oncology, dermatology, and cardiovascular diseases. With a strong academic background and extensive experience in leading clinical research programs, Howard has made significant contributions to drug development in multiple therapeutic areas.